找不到产品?留下需求帮您找
一键询价梅里埃 10400奈瑟氏球菌嗜血菌鉴定盒API NH
两周
面议
梅里埃 API氧化酶试剂
两周
面议
CCFSTTG1 人脑星形细胞瘤 QCH828
一周
3500¥
MM28 人眼葡萄膜黑色瘤細胞 QCH829
一周
5500¥
HCC202 人乳腺原发性导管癌 QCH830
一周
3000¥
HCC2157 人乳腺导管癌细胞(三阴性)QCH831
一周
5000¥
hCMEC/D3-RFP红色荧光蛋白标记的人脑微血管内皮细胞 QCH346R
一周
3500¥
KHYG-1 人NK细胞淋巴瘤细胞 QCH833
一周
3500¥
NCI-h1869 人非小细胞肺癌鳞癌细胞 QCH834
一周
3500¥
NCI-H1417 人小细胞肺癌细胞 QCH835
钦诚生物 | 一周
3500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Bivalirudin TFA 产品别名:见爱必信官网 英文别名:Bivalirudin TFA 靶点:Thrombin CAS:1191386-55-6 纯度:98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder) 描述:Bivalirudin TFA is a synthetic 20 residue peptide which reversibly inhibits thrombin.IC50 Value:Target: thrombinin vitro: Eptifibatide (8 mg/mL) added together with a low (70 ng/mL) concentration of bivalirudin (a direct thrombin inhibitor) effectively (approximately 90%) reduced platelet aggregation induced by thrombin (0.2 U/mL) . In thrombin generation assay (TGA), bivalirudin had no effect on these parameters up to 10 μmol/l . Bivalirudin-facilitated binding of MPO to BAEC resulted also in functional changes in terms of increased NO consumption as well as enhanced MPO-mediated redox modifications .in vivo: The use of bivalirudinprevented further increase in antiheparin/PF4 antibody IgG levels in rats . Three animals in the 500-mg/kg/24 h group, and 7 animals in the 2000-mg/kg/24 h group in the toxicokinetic assessment phase of the study were found dead or euthanized in extremis (following blood sampling). Plasma concentrations of bivalirudin appeared to be linear and dose independent .Clinical trial: Antithrombotic Effects of Ticagrelor Versus Clopidogrel . Phase 4 溶解性: 体外研究: 体内研究:
产品信息订购:
|